eMolecules, Inc., provider of a leading chemistry search-and-fulfillment platform for early drug discovery research, announced the acquisitions of Frontier Scientific Inc. (FSI) and Frontier Agricultural Sciences Inc (FAS). Financial terms of the transactions were not disclosed.
FSI is a leading provider of chemical materials management and custom research services to the pharmaceutical, biotechnology, industrial chemical, government, and academic sectors, helping global organizations reduce time to market, internal costs and resource requirements. FAS is a top provider of research materials to the entomology research community, enabling accelerated development of agricultural chemistry products.
Also Read: Oncopeptides Receives 5 MSEK Grant For NK-cell Engager Project In Multiple Myeloma
All FSI and FAS employees will join eMolecules and will continue to operate out of the companies’ main location in Newark, Delaware, USA.
“We are truly excited to welcome the FSI and FAS teams into the eMolecules family,” said Niko Gubernator, CEO and President of eMolecules. “Our shared dedication to providing outstanding customer service and delivering specialized solutions that simplify the lives of chemistry researchers were the primary drivers behind this combination. We have worked with Frontier for many years and have been impressed and enthused by the talent that will now be joining and complementing our growing team.”
“R&D departments are under enormous pressure to usher drug candidates through clinical development more quickly and at lower operational costs than ever before. This growing expectation, combined with unstable global supply chains, underscores the need for more robust, cost-efficient chemical supply and management solutions,” continued Niko. “FSI’s compound management, sample processing, and chemical analytical and procurement services perfectly complement eMolecules’ revolutionary specialty chemistry search-and-fulfillment offerings. The combined companies will offer a comprehensive suite of capabilities that will help our customers run more efficient R&D programs, even in times of uncertainty. Additionally, FAS’ support of leading agricultural research organizations will serve as an anchor for eMolecules to grow into this important adjacent market.”
“Today’s combining of FSI and FAS with eMolecules marks the beginning of an exciting new chapter for our customers and employees,” said Bert Israelsen, co-owner and Executive Vice President of FSI and FAS. “As part of eMolecules, FSI and FAS will deliver more value to customers due to the expanded breadth and depth of offerings for specialty chemistry research that will be offered from one company. We are thrilled to embark on a new journey with eMolecules that will further transform drug discovery around the world.”